What's Going On With Wuhan General Group?
Wuhan General Group (WUHN) stock rose on Friday after the OTC bioceutical company secured Liviana CBD-infused extra virgin olive oils. Shares of the company were trading higher 0.71% to $0.705 a share on Friday.
Wuhan General, a company focused on alternative plant-based cannabinoids and psilocybin medical research, said that its first batch of Liviana CBD Infused Extra Virgin Olive Oils are ready to hit shelves. The product consists of Estate Select Extra Virgin Olive Oil (EVOO), Chili Pepper Trilogy Infused EVOO and Eureka Lemon-Infused EVOO.
What Does This Mean For Wuhan General Group?
Chaloner, Wuhan's manufacturer, harvests their olives in small batches and cold-presses within 24 hours to keep the natural unique flavors.
"It has been such an amazing experience working with the team at Chaloner in creating a delicious premium EVOO using only the best ingredients. We have worked tirelessly to develop three beautiful EVOO variants which tingle your taste buds and titillate your senses." said Samuel Williams, Head of Food Formulations for M2Bio Sciences.
Wuhan General is convinced it's a product that everyone will want on their shelves.
"Combined with something as incredible as CBD, the Liviana products should be something everyone should have in their kitchen to help maintain peak health and longevity, " said Wuhan General Group CEO Jeff Robinson.
Wuhan General Group (China), Inc., through its subsidiaries, researches, develops, and commercializes a range of cannabidiol (CBD)-based products under the Dr. AnnaRx brand for pharmacies. It also focuses on exploring and developing other indications for psilocybin new therapies that will enable patients who suffer from mental illness.
WUHN has a Short-Term Technical Rank of 52. Find out what this means to you and get the rest of the rankings on WUHN!
M2Bio Sciences Inc is a United States-based nutraceutical biotechnology company. It focuses on alternative plant-based cannabinoids and psilocybin medical research that is into the development and commercialization of CBD and mushrooms-based products. The company's brands include Dr. AnnaRx, Medspresso, and Handcrafted Delight. It is also into research with psilocybin that aims to develop new therapies that will help patients who suffer from alcohol addiction, mental illness, and cardiovascular diseases.
